Understanding RNA Changes in SARS-CoV-2
RNA internal 2’-O methylation in SARS-CoV-2
['FUNDING_R21'] · OHIO STATE UNIVERSITY · NIH-11094746
This project aims to understand how a specific change in the SARS-CoV-2 virus's genetic material helps it multiply inside human cells.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-11094746 on ClinicalTrials.gov |
What this research studies
Our bodies and viruses like SARS-CoV-2 have special marks on their genetic material called RNA, which can change how they work. One such mark, called 2'-O methylation, is common, but we don't fully understand its role when it appears inside the main body of the viral RNA. This project has found these specific marks in SARS-CoV-2 RNA taken from human lung cells. We want to discover which enzymes create these marks and what purpose they serve in the virus's life cycle.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation, but future studies stemming from this work could benefit individuals affected by SARS-CoV-2.
Not a fit: Patients seeking immediate treatment options or direct clinical intervention would not find direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could reveal new ways to disrupt how SARS-CoV-2 replicates, potentially leading to new antiviral treatments.
How similar studies have performed: While the 5' cap 2'-O methylation is well-studied, the specific internal 2'-O methylation sites in SARS-CoV-2 and their functions are newly discovered and largely unexplored.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LI, JIANRONG — OHIO STATE UNIVERSITY
- Study coordinator: LI, JIANRONG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus